Publication | Closed Access

Decrease in dopamine, its metabolites and noradrenaline in cerebrospinal fluid of schizophrenic patients after withdrawal of long-term neuroleptic treatment

Schizophrenic PatientsNeuropsychologyPsychotropic MedicationPsychopharmacologyNeuropsychiatrySocial SciencesCerebrospinal FluidNeurologyLong-term Neuroleptic TreatmentPsychoactive DrugPsychiatryNeuropharmacologyDopamineNeurophysiologyAddictionSchizophreniaNeuroscienceBiological PsychiatryMedicinePsychopathology